✦ LIBER ✦

Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non-Small-Cell Lung Cancer and EGFR Mutations?

✍ Scribed by Haspinger, E. R.; Garassino, M. C.; Torri, V.; Cinquini, M.; De Braud, F.; Gelsomino, F.

Book ID: 126527039
Publisher: American Society of Clinical Oncology
Year: 2014
Tongue: English
Weight: 78 KB
Volume: 32
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2013.52.8794

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN109 Cost Effectiveness of First Line

PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model

✍ Borget, I.; Vergnenegre, A.; Chouaid, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Pretreatment Epidermal Growth Factor Rec

Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non-Small-Cell Lung Cancer

✍ Su, K.-Y.; Chen, H.-Y.; Li, K.-C.; Kuo, M.-L.; Yang, J. C.-H.; Chan, W.-K.; Ho, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 676 KB

Epidermal growth factor receptor tyrosin

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients

✍ Roengvoraphoj, Monic; Tsongalis, Gregory J.; Dragnev, Konstantin H.; Rigas, Jame 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Uncommon Epidermal Growth Factor Recepto

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance

✍ Massarelli, Erminia; Johnson, Faye M.; Erickson, Heidi S.; Wistuba, Ignacio I.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 478 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

Primary resistance to epidermal growth f

Primary resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer harboring TKI-sensitive EGFR mutations: an exploratory study

✍ Lee, J. K.; Shin, J.- Y.; Kim, S.; Lee, S.; Park, C.; Kim, J.- Y.; Koh, Y.; Keam 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 215 KB